CPHI
What one share of China Pharma Holdings holds
Pharmaceutical Preparations
China Pharma is not a Chinese operating company and all the operations are conducted by our wholly owned subsidiary, Hainan Helpson
China Pharma Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.20 |
|---|---|
| Profit | −$0.23 |
| Cash and investments | $0.01 |
| Book value | $0.89 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $178.64 | −$105.35 | $2.22 | $31.00 | — | $675.88 |
| 2017 | $151.59 | −$221.18 | $1.57 | $8.09 | — | $494.17 |
| 2018 | $141.47 | −$123.34 | $0.59 | $21.01 | — | $346.48 |
| 2019 | $125.33 | −$237.52 | $1.56 | $5.42 | — | $105.99 |
| 2020 | $124.55 | −$35.00 | $9.94 | −$10.43 | — | $87.81 |
| 2021 | $104.51 | −$36.85 | $4.75 | −$7.46 | — | $63.56 |
| 2022 | $77.08 | −$37.79 | $3.82 | −$7.72 | — | $28.63 |
| 2023 | $20.72 | −$9.10 | $0.03 | −$2.10 | — | — |
| 2024 | $2.59 | −$2.71 | $0.02 | −$0.25 | — | $2.38 |
| 2025 | $0.97 | −$0.74 | $0.01 | $0.02 | — | $4.12 |